A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
High Grade Glioma · Glioblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Chandler Regional Medical Center, Chandler, Arizona, United States
Contact: Principal Investigator (Kaith Almefty, MD)St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Contact: Principal Investigator (Nader Sanai, MD)
Study leads
Nader Sanai, MD
Principal Investigator
Chief Scientific Officer/Director of the Ivy Brain Tumor Center